Correlation Between Chenghe Acquisition and LAVA Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chenghe Acquisition and LAVA Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chenghe Acquisition and LAVA Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chenghe Acquisition Co and LAVA Medtech Acquisition, you can compare the effects of market volatilities on Chenghe Acquisition and LAVA Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chenghe Acquisition with a short position of LAVA Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chenghe Acquisition and LAVA Medtech.

Diversification Opportunities for Chenghe Acquisition and LAVA Medtech

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chenghe and LAVA is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Chenghe Acquisition Co and LAVA Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAVA Medtech Acquisition and Chenghe Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chenghe Acquisition Co are associated (or correlated) with LAVA Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAVA Medtech Acquisition has no effect on the direction of Chenghe Acquisition i.e., Chenghe Acquisition and LAVA Medtech go up and down completely randomly.

Pair Corralation between Chenghe Acquisition and LAVA Medtech

If you would invest  1,044  in LAVA Medtech Acquisition on September 17, 2024 and sell it today you would earn a total of  0.00  from holding LAVA Medtech Acquisition or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chenghe Acquisition Co  vs.  LAVA Medtech Acquisition

 Performance 
       Timeline  
Chenghe Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chenghe Acquisition Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Chenghe Acquisition is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
LAVA Medtech Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Chenghe Acquisition and LAVA Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chenghe Acquisition and LAVA Medtech

The main advantage of trading using opposite Chenghe Acquisition and LAVA Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chenghe Acquisition position performs unexpectedly, LAVA Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LAVA Medtech will offset losses from the drop in LAVA Medtech's long position.
The idea behind Chenghe Acquisition Co and LAVA Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets